首页> 外文期刊>European journal of health law >European Court of Justice. ECJ 2008/12 Sot. Lelos kai Sia EE and Others v. GlaxoSmithKline AEVE Farmakeftikon Proionton, 16 September 2008 (Joined cases C-486/06 to C-478/06).
【24h】

European Court of Justice. ECJ 2008/12 Sot. Lelos kai Sia EE and Others v. GlaxoSmithKline AEVE Farmakeftikon Proionton, 16 September 2008 (Joined cases C-486/06 to C-478/06).

机译:欧洲法院。 ECJ 2008/12 Sot。 Lelos kai Sia EE及其他人诉GlaxoSmithKline AEVE Farmakeftikon Proionton,2008年9月(合并案C-486 / 06至C-478 / 06)。

获取原文
获取原文并翻译 | 示例
           

摘要

Article 82 EC. A pharmaceuticals company is abusing its dominant position if it refuses to meet ordinary orders by wholesalers in order to prevent parallel imports. Whether orders are ordinary must be ascertained in the light of the needs of the national market in question and previous trading relations.
机译:欧盟第82条。如果一家制药公司拒绝满足批发商的普通订单以防止平行进口,那么它将滥用其主导地位。必须根据有关国家市场的需求和先前的贸易关系确定订单是否普通。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号